Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things…
12/12/2017 - 7 minutes
As 2016 was a tough year for biotech, 2017 was under pressure to turn things…
Cerenis therapeutic's lead candidate CER-001 has failed Phase II for the treatment of patients with…
Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for…